Latest Comments

Novel Hyperkalemia Agents Race Toward the European CKD Market

Novel Hyperkalemia Agents Race Toward the European CKD Market

ESMO 2017: An uncertain future for Merck’s Keytruda

ESMO 2017: An uncertain future for Merck’s Keytruda

An update on PARP inhibitors: ovarian cancer and beyond

An update on PARP inhibitors: ovarian cancer and beyond

Ten-year old NICE restrictions on Velcade limit patient access to next-gen therapies

Ten-year old NICE restrictions on Velcade limit patient access to next-gen therapies

Array BioPharma’s BRAF/MEK combination set for approval review in Europe

Array BioPharma’s BRAF/MEK combination set for approval review in Europe

FDA rejection of Acorda’s Inbrija is another challenge after Ampyra patent setback

FDA rejection of Acorda’s Inbrija is another challenge after Ampyra patent setback

Why has the Industry seen higher numbers of Drug Designations than ever before?

Why has the Industry seen higher numbers of Drug Designations than ever before?

ESC Congress Barcelona 2017 Highlights – What is the Role of Monotherapies in the Treatment of PAH Patients?

ESC Congress Barcelona 2017 Highlights – What is the Role of Monotherapies in the Treatment of PAH Patients?

High Multiple Sclerosis Costs Are Attracting Attention From US Lawmakers

High Multiple Sclerosis Costs Are Attracting Attention From US Lawmakers

Despite Humira patent expiry, Abbvie is poised to remain a market leader in Crohn’s disease

Despite Humira patent expiry, Abbvie is poised to remain a market leader in Crohn’s disease

The future of vaccines – could they really grow on trees?

The future of vaccines – could they really grow on trees?

PARP inhibitors are set to become the new standard of care in BRCA1/2-mutated pancreatic adenocarcinoma

PARP inhibitors are set to become the new standard of care in BRCA1/2-mutated pancreatic adenocarcinoma

Anti-nerve growth factor antibodies expected to drive osteoarthritis market growth

Anti-nerve growth factor antibodies expected to drive osteoarthritis market growth

Novartis launches first smartphone-based study in MS

Novartis launches first smartphone-based study in MS

Could the first new sickle cell drug in 20 years provide hope for sufferers?

Could the first new sickle cell drug in 20 years provide hope for sufferers?

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles

BMS shifts towards precision medicine

BMS shifts towards precision medicine

pSivida and Alimera enter new phase of collaboration on the longest-acting ocular steroid implant

pSivida and Alimera enter new phase of collaboration on the longest-acting ocular steroid implant

Amgen and Array BioPharma partnership: creating waves in autoimmune disorder market

Amgen and Array BioPharma partnership: creating waves in autoimmune disorder market

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement

The role of the media in determining health views

The role of the media in determining health views